Item Type | Name |
Academic Article
|
Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness.
|
Academic Article
|
Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.
|
Academic Article
|
Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents.
|
Academic Article
|
Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion.
|
Academic Article
|
Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD).
|
Academic Article
|
Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator.
|
Academic Article
|
A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.
|
Concept
|
Acetaminophen
|
Concept
|
Alkaline Phosphatase
|
Concept
|
Aluminum
|
Concept
|
Amides
|
Concept
|
Aminophenols
|
Concept
|
Anthraquinones
|
Concept
|
Antifungal Agents
|
Concept
|
Antineoplastic Agents
|
Concept
|
Arginine
|
Concept
|
Aromatase
|
Concept
|
Bacterial Proteins
|
Concept
|
Benzamidines
|
Concept
|
Benzhydryl Compounds
|
Concept
|
Bibenzyls
|
Concept
|
Binding Sites
|
Concept
|
Boronic Acids
|
Concept
|
Calcium-Binding Proteins
|
Concept
|
Cannabinoids
|
Concept
|
Carbon Monoxide
|
Concept
|
Carrier Proteins
|
Concept
|
Colchicine
|
Concept
|
Collagen
|
Concept
|
Coumarins
|
Concept
|
Curcumin
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
Deoxycholic Acid
|
Concept
|
Deoxyribonucleases
|
Concept
|
Detergents
|
Concept
|
DNA
|
Concept
|
Dose-Response Relationship, Drug
|
Concept
|
Drug Carriers
|
Concept
|
Drug Combinations
|
Concept
|
Drug Resistance
|
Concept
|
Drug Evaluation, Preclinical
|
Concept
|
Drug Screening Assays, Antitumor
|
Concept
|
Pharmaceutical Preparations
|
Concept
|
Equipment Design
|
Concept
|
Estradiol
|
Concept
|
Estrogen Antagonists
|
Concept
|
Estrogens
|
Concept
|
Ethinyl Estradiol
|
Concept
|
Fixatives
|
Concept
|
Glutarates
|
Concept
|
Glycosaminoglycans
|
Concept
|
Graphite
|
Concept
|
Histone Deacetylases
|
Concept
|
Hydrocarbons, Chlorinated
|
Concept
|
Hydroxides
|
Concept
|
Hypochlorous Acid
|
Concept
|
Indoles
|
Concept
|
Indomethacin
|
Concept
|
Isoflavones
|
Concept
|
Laminin
|
Concept
|
Ligands
|
Concept
|
Lipids
|
Concept
|
Marine Toxins
|
Concept
|
Microfilament Proteins
|
Concept
|
Morpholines
|
Concept
|
Naphthalenes
|
Concept
|
Neoplasm Proteins
|
Concept
|
Nickel
|
Concept
|
Nitriles
|
Concept
|
Nitrogen Mustard Compounds
|
Concept
|
Oxadiazoles
|
Concept
|
Oxazines
|
Concept
|
Oximes
|
Concept
|
Oxygen
|
Concept
|
Pentanones
|
Concept
|
Pesticides
|
Concept
|
Phenols
|
Concept
|
Piperazines
|
Concept
|
Piperidines
|
Concept
|
Polychlorinated Biphenyls
|
Concept
|
Prodrugs
|
Concept
|
Proteoglycans
|
Concept
|
Pyrazoles
|
Concept
|
Pyridines
|
Concept
|
Receptors, Drug
|
Concept
|
Receptors, Estrogen
|
Concept
|
Receptors, Progesterone
|
Concept
|
RNA, Messenger
|
Concept
|
Saline Solution, Hypertonic
|
Concept
|
Soil Pollutants
|
Concept
|
Stereoisomerism
|
Concept
|
Sterols
|
Concept
|
Sulfonamides
|
Concept
|
Tablets
|
Concept
|
Tamoxifen
|
Concept
|
Thiazoles
|
Concept
|
Triazoles
|
Concept
|
Trypanocidal Agents
|
Concept
|
Tubulin
|
Concept
|
Tumor Necrosis Factor-alpha
|
Concept
|
Monophenol Monooxygenase
|
Concept
|
Vimentin
|
Concept
|
Water Pollutants
|
Concept
|
Water Pollutants, Chemical
|
Concept
|
Drug Design
|
Concept
|
Interleukin-6
|
Concept
|
Extracellular Matrix Proteins
|
Concept
|
Apoptosis
|
Concept
|
Receptors, Cytoplasmic and Nuclear
|
Concept
|
Receptors, Aryl Hydrocarbon
|
Concept
|
Antineoplastic Agents, Hormonal
|
Concept
|
Cystic Fibrosis Transmembrane Conductance Regulator
|
Concept
|
Drug Resistance, Neoplasm
|
Concept
|
Cytochrome P-450 CYP1A2
|
Concept
|
Cytochrome P-450 CYP2D6
|
Concept
|
Insect Proteins
|
Concept
|
Genistein
|
Concept
|
Response Elements
|
Concept
|
Angiogenesis Inhibitors
|
Concept
|
Proteome
|
Concept
|
Leptin
|
Concept
|
rhoA GTP-Binding Protein
|
Concept
|
Selective Estrogen Receptor Modulators
|
Concept
|
RNA, Small Interfering
|
Concept
|
Oxocins
|
Concept
|
Nanotubes, Carbon
|
Concept
|
Taxoids
|
Concept
|
Receptors, Cannabinoid
|
Concept
|
Receptor, Cannabinoid, CB2
|
Concept
|
Aromatase Inhibitors
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Estrogen Receptor alpha
|
Concept
|
Mitogen-Activated Protein Kinase 7
|
Concept
|
Benzoxazines
|
Concept
|
MAP Kinase Kinase 5
|
Concept
|
Phytoestrogens
|
Concept
|
Bone Density Conservation Agents
|
Concept
|
Tubulin Modulators
|
Concept
|
STAT3 Transcription Factor
|
Concept
|
Receptors, Notch
|
Concept
|
Endocrine Disruptors
|
Concept
|
Cyclooxygenase 2 Inhibitors
|
Concept
|
Receptors, Leptin
|
Concept
|
rho-Associated Kinases
|
Concept
|
Small Molecule Libraries
|
Concept
|
Drug Discovery
|
Concept
|
Histone Deacetylase Inhibitors
|
Academic Article
|
Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration.
|
Grant
|
Xavier RCMI Center for Cancer Research
|
Academic Article
|
In vitro metabolism of R(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo [1,2,3-de]1,4-benzoxazinyl]-(1-naphthalenyl) methanone mesylate, a cannabinoid receptor agonist.
|
Academic Article
|
In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands.
|
Academic Article
|
Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
|
Academic Article
|
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
|
Academic Article
|
Design and synthesis of N?,N5-bis[4-(5-alkyl-1,2,4-oxadiazol-3-yl)phenyl]glutaramides as potential antifungal prodrugs.
|
Academic Article
|
Advances in the proteomic discovery of novel therapeutic targets in cancer.
|
Academic Article
|
Hypertensive rat lungs retain hallmarks of vascular disease upon decellularization but support the growth of mesenchymal stem cells.
|
Academic Article
|
Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.
|
Academic Article
|
Design, synthesis, and osteogenic activity of daidzein analogs on human mesenchymal stem cells.
|
Academic Article
|
Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer.
|
Academic Article
|
Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
|
Academic Article
|
Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer.
|
Academic Article
|
Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach.
|
Academic Article
|
Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms.
|
Academic Article
|
Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents.
|
Academic Article
|
Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status.
|
Academic Article
|
Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics.
|
Academic Article
|
Ligands of Therapeutic Utility for the Liver X Receptors.
|
Academic Article
|
Design and synthesis of a novel ZB716-d6 as a stable isotopically labeled internal standard.
|
Academic Article
|
Design, Synthesis, and Evaluation of Niclosamide Analogs as Therapeutic Agents for Enzalutamide-Resistant Prostate Cancer.
|